ASML vs GCTS

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

GCTS exhibits critical financial distress, highlighted by a Piotroski F-Score of 1/9 and a catastrophic Current Ratio of 0.15, indicating a severe liquidity crisis. The company is operating with negative gross margins (-63.40%) and collapsing revenue growth (-57.50% YoY), suggesting a fundamental failure in its business model. With a negative Price-to-Book ratio (-0.94), the company has effectively wiped out its equity. Despite a 'strong_buy' analyst consensus, the deterministic data points toward a high risk of insolvency.